A social distancing measure governing the whole proteome
SI Choi, BL Seong - Current opinion in structural biology, 2021 - Elsevier
Protein folding in vivo has been largely understood in the context of molecular chaperones
preventing aggregation of nascent polypeptides in the crowded cellular environment …
preventing aggregation of nascent polypeptides in the crowded cellular environment …
Genetic Variation in Complex Traits in Transgenic α-Synuclein Strains of Caenorhabditis elegans
Different genetic backgrounds can modify the effect of mutated genes. Human α-synuclein
(SNCA) gene encodes α-synuclein, and its oligomeric complexes accumulate with age and …
(SNCA) gene encodes α-synuclein, and its oligomeric complexes accumulate with age and …
Rapid formation of peptide/lipid coaggregates by the amyloidogenic seminal peptide PAP248-286
EW Vane, S He, L Maibaum, A Nath - Biophysical Journal, 2020 - cell.com
Protein/lipid coassembly is an understudied phenomenon that is important to the function of
antimicrobial peptides as well as the pathological effects of amyloid. Here, we study the …
antimicrobial peptides as well as the pathological effects of amyloid. Here, we study the …
The conformational ensemble of an intrinsically disordered protein explains peak shapes under DNP conditions
J Kragelj, R Dumarieh, Y Xiao, KK Frederick - bioRxiv, 2022 - biorxiv.org
Elucidating the conformational preferences of regions of intrinsic disorder in biologically
relevant contexts represents a frontier of structural biology. The sensitivity enhancements …
relevant contexts represents a frontier of structural biology. The sensitivity enhancements …
Targeting pathological alpha-synuclein: Protein engineering towards improved antibody-based therapeutics and their delivery to the brain
I Petersen - 2024 - diva-portal.org
Abstract Petersen, I. 2024. Targeting pathological alpha-synuclein. Protein engineering
towards improved antibody-based therapeutics and their delivery to the brain. Digital …
towards improved antibody-based therapeutics and their delivery to the brain. Digital …
Fluorescence microscopy studies of interactions between monomeric α-Synuclein and lipid membranes
A Andersson - 2023 - portal.research.lu.se
Abstract α-Synuclein (α-Syn), is an intrinsically disordered protein present in the substantia
nigra part of the brain. α-Syn is commonly known to associate with lipid membranes …
nigra part of the brain. α-Syn is commonly known to associate with lipid membranes …
Exploring the Effect of Changes in Plasma and Organelle Membranes on Alphasynuclein Aggregation
T Dou - 2023 - oaktrust.library.tamu.edu
Parkinson's disease (PD) is the second-most common neurodegenerative disorder among
seniors after Alzheimer's disease, affecting 2-3% of the population over 65 years old. While …
seniors after Alzheimer's disease, affecting 2-3% of the population over 65 years old. While …
Structural studies of human Aquaporin-1 in polymer nanodiscs and an investigation into a conserved hydrogen-bond network crucial for stability
P Drewniak - 2023 - atrium.lib.uoguelph.ca
Abstract The human Aquaporin-1 (AQP1) membrane protein is integral towards many
cellular processes involved with water permeability. This thesis explores two separate …
cellular processes involved with water permeability. This thesis explores two separate …
[PDF][PDF] Insights into the structure, kinetics and aggregation of α-synuclein by charged metabolites
FJS Brigham - 2023 - run.unl.pt
Alpha-Synuclein (αS) is a small intrinsically disordered protein (IDP) abundantly expressed
in presynaptic terminals of neurons that displays a highly amyloidogenic nature …
in presynaptic terminals of neurons that displays a highly amyloidogenic nature …
[PDF][PDF] Einzelpartikelanalyse zur Diagnose von Morbus Alzheimer und Morbus Parkinson
AS Dybala - 2022 - docserv.uni-duesseldorf.de
Morbus Alzheimer ist die häufigste altersbedingte neurodegenerative Krankheit und die
häufigste Ursache für eine Demenzerkrankung. Die Alzheimer-Krankheit ist bisher nicht …
häufigste Ursache für eine Demenzerkrankung. Die Alzheimer-Krankheit ist bisher nicht …